|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
11 January 2021 |
|
Main ID: |
NCT03351504 |
|
Date of registration:
|
19/11/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Solar Lighting to Reduce Indoor Air Pollution in Rural Uganda
|
|
Scientific title:
|
Solar Lighting Intervention Trial to Reduce Indoor Air Pollution and Improve Adult Respiratory Health in Rural Uganda |
|
Date of first enrolment:
|
February 7, 2018 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03351504 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Uganda
|
United States
| | | | | | |
|
Contacts
|
|
Name:
|
Peggy S Lai, MD MPH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Massachusetts General Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Women living in Nyakabare Parish, Uganda with no prior history of chronic lung disease
Exclusion Criteria:
- Current active tuberculosis in any family member
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Pollution Related Respiratory Disorder
|
|
Hypertension
|
|
Pollution; Exposure
|
|
Intervention(s)
|
|
Other: Solar lighting system
|
|
Primary Outcome(s)
|
|
Fine particulate matter (PM2.5) and Black Carbon
[Time Frame: 48 hour]
|
|
Secondary Outcome(s)
|
|
Daily use of solar lighting system (hours per day)
[Time Frame: baseline, 3 months, 6 months, 12 months after the intervention]
|
|
Blood pressure
[Time Frame: baseline, 3 months, 6 months, 12 months after the intervention]
|
|
Heart rate variability
[Time Frame: baseline, 3 months, 6 months, 12 months after the intervention]
|
|
Forced Expiratory Volume in one Second (FEV1)
[Time Frame: baseline, 3 months, 6 months, 12 months after the intervention]
|
|
Qualitative interviews
[Time Frame: Post-intervention]
|
|
Stool microbiome
[Time Frame: baseline, 3 months, 6 months, 12 months after the intervention]
|
|
Secondary ID(s)
|
|
2017P000306/PHS
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|